PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportsparkinson disease
MeSH D010300 - parkinson disease
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D020734:Parkinsonian disorders
1 Company
1 Drug
$
Success rate
D000080874:Synucleinopathies
0 Companies
0 Drugs
Success rate
D010300: 
Parkinson disease
106 Companies
30 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
1 A PharmaRivastigmine Rivastigmine 1 A Pharma  2009-12-11   
Abbott BiotherapeuticsApomorphine Taluvian  2001-05-28   
Apomorphine Uprima  2001-05-28   
AbbVieLevodopa, Carbidopa hydrate Duopa  2015-01-09 $412 M Q3/24-Q2/25 
Acadia PharmaceuticalsPimavanserin Nuplazid 2022-07-27 2016-04-29   
Accord HealthcareLevodopa, Carbidopa hydrate Carbidopa Levodopa  2013-02-08   
Pramipexole Pramipexole Accord  2011-09-29   
Ropinirole Ropinirole  2017-02-28   
Acorda TherapeuticsLevodopa Inbrija  2019-09-19 $5.974 M Q2/23-Q1/24 
Ajanta PharmaEntacapone Entacapone  2017-08-31   
Alembic PharmaceuticalsAmantadine Amantadine  2017-06-21   
Levodopa, Carbidopa hydrate Carbidopa Levodopa  2019-06-05   
Entacapone Entacapone  2022-01-04   
Pramipexole Pramipexole  2010-10-08   
Ropinirole Ropinirole  2010-03-24   
Alkem LaboratoriesRasagiline Rasagiline  2017-10-30   
AllerganAmantadine Amantadine  1987-01-21   
Cabergoline Cabergoline  2008-04-21   
Levodopa, Carbidopa hydrate Carbidopa Levodopa  1993-09-28   
Pramipexole Pramipexole  2016-04-21   
Rasagiline Rasagiline  2013-07-01   
Rivastigmine Rivastigmine Actavis  2011-06-16   
Ropinirole Ropinirole  2012-05-17   
1
2
3
4
5
6
...
11
>
Clinical Trials
Historical Success Rate
Phase 1
64%
62/97
Phase 2
46%
72/155
Phase 3
59%
64/108
Approved: 33Overall Success rate: 18%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
Dexpramipexole,
Pardoprunox,
Duodopa,
Ipx066
AbbVie
Levodopa,
Carbidopa hydrate,
Foslevodopa,
Foscarbidopa,
Tavapadon,
Phenylalanine,
Pegargiminase,
Bevifimod,
Nepidermin,
Duodopa,
Histone-arginine methyltransferase carm1,
Surlorian,
Ipx066,
Isoxaflutole
Acadia Pharmaceuticals
Pimavanserin,
Fluorodopa f-18,
Fludeoxyglucose f-18
Acorda Therapeutics
Levodopa,
Tozadenant,
Phenylalanine,
Bevifimod,
LANDIPIRDINE,
Ipx066
Allergan
Levodopa,
Amantadine,
Enoblituzumab,
Bevifimod,
Azzalure
Amneal Pharmaceuticals
Levodopa,
Carbidopa hydrate,
Isoxaflutole
1
2
3
4
5
6
...
8
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use